Cargando…

DPP4-directed therapeutic strategies for MERS-CoV

Detalles Bibliográficos
Autores principales:	Reinhold, Dirk, Brocke, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2014
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128741/ https://www.ncbi.nlm.nih.gov/pubmed/24457167 http://dx.doi.org/10.1016/S1473-3099(13)70696-0

Ejemplares similares

Adaptive Evolution of MERS-CoV to Species Variation in DPP4
por: Letko, Michael, et al.
Publicado: (2018)

The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike
por: Li, Yu, et al.
Publicado: (2020)

The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike
por: Li, Yu, et al.
Publicado: (2020)

Identification of residues on human receptor DPP4 critical for MERS-CoV binding and entry
por: Song, Wenfei, et al.
Publicado: (2014)

The differential roles of zinc in immune responses and their potential implications in antiviral immunity against SARS-CoV-2
por: Reinhold, Dirk, et al.
Publicado: (2021)

Inability of rat DPP4 to allow MERS-CoV infection revealed by using a VSV pseudotype bearing truncated MERS-CoV spike protein
por: Fukuma, Aiko, et al.
Publicado: (2015)

Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
por: Wang, Nianshuang, et al.
Publicado: (2013)

A Human DPP4-Knockin Mouse’s Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV
por: Fan, Changfa, et al.
Publicado: (2018)

Sunitinib reduces the infection of SARS-CoV, MERS-CoV and SARS-CoV-2 partially by inhibiting AP2M1 phosphorylation
por: Wang, Pei-Gang, et al.
Publicado: (2020)

A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection
por: Tai, Wanbo, et al.
Publicado: (2016)

Unraveling DPP4 Receptor Interactions with SARS-CoV-2 Variants and MERS-CoV: Insights into Pulmonary Disorders via Immunoinformatics and Molecular Dynamics
por: Roy, Arpan Narayan, et al.
Publicado: (2023)

MERS-CoV infection causes brain damage in human DPP4-transgenic mice through complement-mediated inflammation
por: Jiang, Yuting, et al.
Publicado: (2021)

Intranasally administered peptidic viral fusion inhibitor protected hDPP4 transgenic mice from MERS-CoV infection
por: Jiang, Shibo, et al.
Publicado: (2015)

MERS-CoV
por: Müller, Marcel A
Publicado: (2014)

Vaccination strategies for mitigation of MERS-CoV outbreaks
por: Bosaeed, Mohammad, et al.
Publicado: (2023)

MERS-CoV recently re-emerged in Qatar, Saudi Arabia, its feasible global health risks amid FIFA world cup 2022 and salient counteracting strategies – an update
por: Chopra, Hitesh, et al.
Publicado: (2023)

Immunization of MERS-CoV-2-infected mice with a sublethal dose of MERS-CoV or VRP-MERS-S
por: Zheng, Jian, et al.
Publicado: (2023)

Complement Receptor C5aR1 Inhibition Reduces Pyroptosis in hDPP4-Transgenic Mice Infected with MERS-CoV
por: Jiang, Yuting, et al.
Publicado: (2019)

The epidemiology of MERS-CoV
por: Fisman, David N, et al.
Publicado: (2014)

MERS-CoV spike protein: Targets for vaccines and therapeutics
por: Wang, Qihui, et al.
Publicado: (2016)

One Health-based control strategies for MERS-CoV
por: Hemida, M.
Publicado: (2020)

MERS-CoV spike nanoparticles protect mice from MERS-CoV infection
por: Coleman, Christopher M., et al.
Publicado: (2017)

MERS-CoV Infection of Alpaca in a Region Where MERS-CoV is Endemic
por: Reusken, Chantal B.E.M., et al.
Publicado: (2016)

Modulation of IRAK enzymes as a therapeutic strategy against SARS-CoV-2 induced cytokine storm
por: Mahmoud, Ismail Sami, et al.
Publicado: (2023)

Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model
por: Munster, Vincent J., et al.
Publicado: (2017)

Outpatient strategies and the changing SARS-CoV-2 epidemic
por: Wei, Yanqiu, et al.
Publicado: (2020)

A strategy for SARS-CoV-2 vaccination in Yemen
por: Nasser, Abdullah, et al.
Publicado: (2021)

Isolation of MERS-related coronavirus from lesser bamboo bats that uses DPP4 and infects human-DPP4-transgenic mice
por: Lau, Susanna K. P., et al.
Publicado: (2021)

A Novel Purification Procedure for Active Recombinant Human DPP4 and the Inability of DPP4 to Bind SARS-CoV-2
por: Xi, Cecy R, et al.
Publicado: (2020)

MERS-CoV: epidemiology, molecular dynamics, therapeutics, and future challenges
por: Rabaan, Ali A., et al.
Publicado: (2021)

Current advancements and potential strategies in the development of MERS-CoV vaccines
por: Zhang, Naru, et al.
Publicado: (2014)

MERS-CoV diagnosis: An update
por: Al Johani, Sameera, et al.
Publicado: (2016)

Mers-CoV and Zika Virus
por: Bindenagel Šehović, Annamarie
Publicado: (2017)

MERS-CoV: in search of answers
por: Petherick, Anna
Publicado: (2013)

Molecular aspects of MERS-CoV
por: Rabaan, Ali A., et al.
Publicado: (2017)

Blockade of the C5a–C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV
por: Jiang, Yuting, et al.
Publicado: (2018)

Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Li, Jin-Yan, et al.
Publicado: (2021)

MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS – MERS, MERS CoV
Publicado: (2017)

Ebselen, a new candidate therapeutic against SARS-CoV-2
por: Haritha, C.V., et al.
Publicado: (2020)

Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination
por: Hammerschmidt, Swantje I., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g870fjgohaj8fnurftfhu347nj